Latest News

MS Voice Newsletter – May 2024: World MS Day Special Edition

May 30, 2024 | Life with MS, MS Voice, My Story, News, Newsletter, Treatments

Welcome to the 2024 World MS Day Special Edition of MS Voice – your trusted source for the latest updates, information and inspiring stories from Multiple Sclerosis New Zealand.

World MS Day is an international awareness day for everyone affected by multiple sclerosis. It is officially marked on 30th May every year to bring the global MS community together to share stories, raise awareness and campaign for change 🧡 The 2024 ‘My MS Diagnosis’ campaign advocates for early and accurate diagnosis for everyone living with MS. It highlights the global barriers to diagnosing MS, raises awareness by sharing real stories, and data. We are calling for better MS training for healthcare professionals, new research, and clinical advancements in MS diagnosis. Together we are building informed, caring communities and systems that support those diagnosed. Read more in the articles below.

In this edition, we are asking those on infusion treatments to get in touch. We want to know how the new alternative subcutaneous versions of current DMTs that are sitting on Pharmac’s Options for Investments list would help you overcome barriers you face in accessing infusions.

We share great news for people in Canterbury waiting to receive Ocrelizumab, invite you to a Brain Health seminar with Professor Helmut Butzkueven and introduce you to some of our wonderful readers that share their journey to diagnosis with us.

We’re thrilled to say we are getting closer to reaching our goal of raising $20,000 from Bangers to Bluff last month. These vital funds will support people impacted by MS, so please donate, if you can. Thank you 🚗🧡🚴‍♀️

View MS Voice May 2024 online here.

View MS Voice – May 2024 here.

If you would like to receive MS Voice direct to your inbox, please subscribe here.

If you would like to share your story in MS Voice, or have an article that would be useful to our MS Community, please get in touch: or